Ventricular Assist Devices. The Challenges of Outpatient Management

Journal of the American College of Cardiology

Volumn 54, Issue 18, 2009, Pages 1647-1659

  Wilson, Sean R ^a   Givertz, Michael M ^b   Stewart, Garrick C ^b   Mudge Jr , Gilbert H ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

education; heart failure; outpatient management; ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ANTICOAGULANT THERAPY; ASSISTED CIRCULATION; CARDIOVERSION; DEFIBRILLATOR; DEVICE INFECTION; DEVICE THERAPY; DIET THERAPY; EXERCISE; HEART FAILURE; HEART INFARCTION; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HEMODYNAMICS; HUMAN; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RESUSCITATION; REVIEW; THROMBOSIS; TREATMENT INDICATION;

AMBULATORY CARE; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MYOCARDIAL INFARCTION; OUTPATIENTS; PATIENT EDUCATION AS TOPIC; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 70349989042     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.06.035     Document Type: Review

References (83)

1. Levy D., Kenchaiah S., Larson M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347 (2002) 1397-1402
2. Foody J.M., Farrell M.H., and Krumholz H.M. Beta-blocker therapy in heart failure: scientific review. JAMA 287 (2002) 883-889
3. McAlister F.A., Lawson F.M., Teo K.K., and Armstrong P.W. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 110 (2001) 378-384
4. American Heart Association. Heart disease and stroke statistics-2008 update (2008), American Heart Association, Dallas, TX
5. Berry C., Murdoch D.R., and McMurray J.J. Economics of chronic heart failure. Eur J Heart Fail 3 (2001) 283-291
6. U.S. Department of Health and Human Services. 2007 annual report of the U.S. organ procurement and transplantation network and the scientific registry of transplant recipients: transplant data 1997-2006. In: Health Resources and Services Administration (2007), U.S. Department of Health and Human Services, Rockville, MD
7. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
8. Goldstein D.J. Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation 108 Suppl 1 (2003) II272-II277
9. Frazier O.H., Myers T.J., Westaby S., and Gregoric I.D. Clinical experience with an implantable, intracardiac, continuous flow circulatory support device: physiologic implications and their relationship to patient selection. Ann Thorac Surg 77 (2004) 133-142
10. Esmore D., Spratt P., Larbalestier R., et al. VentrAssist left ventricular assist device: clinical trial results and Clinical Development Plan update. Eur J Cardiothorac Surg 32 (2007) 735-744
11. Miller L.W., Pagani F.D., Russell S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357 (2007) 885-896
12. Klotz S., Stypmann J., Welp H., et al. Does continuous flow left ventricular assist device technology have a positive impact on outcome pretransplant and posttransplant?. Ann Thorac Surg 82 (2006) 1774-1778
13. Thalmann M., Schima H., Wieselthaler G., and Wolner E. Physiology of continuous blood flow in recipients of rotary cardiac assist devices. J Heart Lung Transplant 24 (2005) 237-245
14. Radovancevic B., Vrtovec B., de Kort E., Radovancevic R., Gregoric I.D., and Frazier O.H. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant 26 (2007) 815-818
15. Haft J., Armstrong W., Dyke D.B., et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation 116 (2007) I8-I15
16. Bolno P.B., and Kresh J.Y. Physiologic and hemodynamic basis of ventricular assist devices. Cardiol Clin 21 (2003) 15-27
17. Klotz S., Foronjy R.F., Dickstein M.L., et al. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation 112 (2005) 364-374
18. Blaxall B.C., Tschannen-Moran B.M., Milano C.A., and Koch W.J. Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 41 (2003) 1096-1106
19. Bruckner B.A., Stetson S.J., Farmer J.A., et al. The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content. Am J Surg 180 (2000) 498-501
20. Burkhoff D., Holmes J.W., Madigan J., Barbone A., and Oz M.C. Left ventricular assist device-induced reverse ventricular remodeling. Prog Cardiovasc Dis 43 (2000) 19-26
21. Mancini D.M., Beniaminovitz A., Levin H., et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation 98 (1998) 2383-2389
22. Birks E.J., Tansley P.D., Hardy J., et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355 (2006) 1873-1884
23. Grady K.L., Meyer P.M., Mattea A., et al. Change in quality of life from before to after discharge following left ventricular assist device implantation. J Heart Lung Transplant 22 (2003) 322-333
24. Deng M.C., Loebe M., El-Banayosy A., et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation 103 (2001) 231-237
25. Mielniczuk L., Mussivand T., Davies R., et al. Patient selection for left ventricular assist devices. Artif Organs 28 (2004) 152-157
26. de Jonge N., Kirkels H., Lahpor J.R., et al. Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting?. J Am Coll Cardiol 37 (2001) 1794-1799
27. Foray A., Williams D., Reemtsma K., Oz M., and Mancini D. Assessment of submaximal exercise capacity in patients with left ventricular assist devices. Circulation 94 (1996) II222-II226
28. Khan T., Levin H.R., Oz M.C., and Katz S.D. Delayed reversal of impaired metabolic vasodilation in patients with end-stage heart failure during long-term circulatory support with a left ventricular assist device. J Heart Lung Transplant 16 (1997) 449-453
29. Anker S.D., Chua T.P., Ponikowski P., et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 96 (1997) 526-534
30. Dang N.C., Topkara V.K., Kim B.T., Lee B.J., Remoli R., and Naka Y. Nutritional status in patients on left ventricular assist device support. J Thorac Cardiovasc Surg 130 (2005) e3-e4
31. Holdy K., Dembitsky W., Eaton L.L., et al. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant 24 (2005) 1690-1696
32. Schmid C., Hammel D., Deng M.C., et al. Ambulatory care of patients with left ventricular assist devices. Circulation 100 (1999) II224-II228
33. Slaughter M.S., Sobieski M.A., Martin M., Dia M., and Silver M.A. Home discharge experience with the Thoratec TLC-II portable driver. Asaio J 53 (2007) 132-135
34. Klodell C.T., Staples E.D., Aranda Jr. J.M., et al. Managing the post-left ventricular assist device patient. Congest Heart Fail 12 (2006) 41-45
35. Bonaros N., Mueller M.R., Salat A., et al. Extensive coagulation monitoring in patients after implantation of the MicroMed Debakey continuous flow axial pump. Asaio J 50 (2004) 424-431
36. Matsubayashi H., Fastenau D.R., and McIntyre J.A. Changes in platelet activation associated with left ventricular assist system placement. J Heart Lung Transplant 19 (2000) 462-468
37. Gum P.A., Kottke-Marchant K., Poggio E.D., et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88 (2001) 230-235
38. Fries D., Innerhofer P., Streif W., et al. Coagulation monitoring and management of anticoagulation during cardiac assist device support. Ann Thorac Surg 76 (2003) 1593-1597
39. Geisen U., Heilmann C., Beyersdorf F., et al. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur J Cardiothorac Surg 33 (2008) 679-684
40. Crow S., John R., Boyle A., et al. Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J Thorac Cardiovasc Surg 137 (2009) 208-215
41. Letsou G.V., Shah N., Gregoric I.D., Myers T.J., Delgado R., and Frazier O.H. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 24 (2005) 105-109
42. Daas A.Y., Small M.B., Pinkas H., and Brady P.G. Safety of conventional and wireless capsule endoscopy in patients supported with nonpulsatile axial flow Heart-Mate II left ventricular assist device. Gastrointest Endosc 68 (2008) 379-382
43. Oswald H., Klein G., Struber M., and Gardiwal A. Implantable defibrillator with left ventricular assist device compatibility. Interact Cardiovasc Thorac Surg 8 (2009) 579-580
44. Bigger Jr. J.T., Fleiss J.L., Kleiger R., Miller J.P., and Rolnitzky L.M. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 69 (1984) 250-258
45. Oz M.C., Rose E.A., Slater J., Kuiper J.J., Catanese K.A., and Levin H.R. Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices. J Am Coll Cardiol 24 (1994) 1688-1691
46. Bedi M., Kormos R., Winowich S., McNamara D.M., Mathier M.A., and Murali S. Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol 99 (2007) 1151-1153
47. Andersen M., Videbaek R., Boesgaard S., Sander K., Hansen P.B., and Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant 28 (2009) 733-735
48. Vollkron M., Voitl P., Ta J., Wieselthaler G., and Schima H. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant 26 (2007) 819-825
49. Long J.W., Kfoury A.G., Slaughter M.S., et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 11 (2005) 133-138
50. Long J.W., Healy A.H., Rasmusson B.Y., et al. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. J Thorac Cardiovasc Surg 135 (2008) 1353-1360
51. Gordon R.J., Quagliarello B., and Lowy F.D. Ventricular assist device-related infections. Lancet Infect Dis 6 (2006) 426-437
52. Piccione Jr. W. Left ventricular assist device implantation: short and long-term surgical complications. J Heart Lung Transplant 19 (2000) S89-S94
53. Birks E.J., Tansley P.D., Yacoub M.H., et al. Incidence and clinical management of life-threatening left ventricular assist device failure. J Heart Lung Transplant 23 (2004) 964-969
54. Horton S.C., Khodaverdian R., Chatelain P., et al. Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol 45 (2005) 1435-1440
55. Catena E., Milazzo F., Montorsi E., et al. Left ventricular support by axial flow pump: the echocardiographic approach to device malfunction. J Am Soc Echocardiogr 18 (2005) 1422 e7-13
56. Horton S.C., Khodaverdian R., Powers A., et al. Left ventricular assist device malfunction: a systematic approach to diagnosis. J Am Coll Cardiol 43 (2004) 1574-1583
57. Scalia G.M., McCarthy P.M., Savage R.M., Smedira N.G., and Thomas J.D. Clinical utility of echocardiography in the management of implantable ventricular assist devices. J Am Soc Echocardiogr 13 (2000) 754-763
58. Pae W.E., Connell J.M., Boehmer J.P., et al. Neurologic events with a totally implantable left ventricular assist device: European LionHeart Clinical Utility Baseline Study (CUBS). J Heart Lung Transplant 26 (2007) 1-8
59. Thomas C.E., Jichici D., Petrucci R., Urrutia V.C., and Schwartzman R.J. Neurologic complications of the Novacor left ventricular assist device. Ann Thorac Surg 72 (2001) 1311-1315
60. Lazar R.M., Shapiro P.A., Jaski B.E., et al. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation 109 (2004) 2423-2427
61. Tsukui H., Abla A., Teuteberg J.J., et al. Cerebrovascular accidents in patients with a ventricular assist device. J Thorac Cardiovasc Surg 134 (2007) 114-123
62. Slaughter M.S., Sobieski M.A., Gallagher C., Dia M., and Silver M.A. Low incidence of neurologic events during long-term support with the HeartMate XVE left ventricular assist device. Tex Heart Inst J 35 (2008) 245-249
63. Simon D., Fischer S., Grossman A., et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis 40 (2005) 1108-1115
64. Kalya A.V., Tector A.J., Crouch J.D., et al. Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution. J Heart Lung Transplant 24 (2005) 1973-1975
65. Sivaratnam K., and Duggan J.M. Left ventricular assist device infections: three case reports and a review of the literature. Asaio J 48 (2002) 2-7
66. Sinha P., Chen J.M., Flannery M., Scully B.E., Oz M.C., and Edwards N.M. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation 102 (2000) III194-III199
67. Gordon S.M., Schmitt S.K., Jacobs M., et al. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg 72 (2001) 725-730
68. Nurozler F., Argenziano M., Oz M.C., and Naka Y. Fungal left ventricular assist device endocarditis. Ann Thorac Surg 71 (2001) 614-618
69. Robbins R.C., Kown M.H., Portner P.M., and Oyer P.E. The totally implantable Novacor left ventricular assist system. Ann Thorac Surg 71 (2001) S162-S165
70. Holman W.L., Park S.J., Long J.W., et al. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 23 (2004) 1359-1365
71. Chinn R., Dembitsky W., Eaton L., et al. Multicenter experience: prevention and management of left ventricular assist device infections. Asaio J 51 (2005) 461-470
72. Pasque M.K., Hanselman T., Shelton K., et al. Surgical management of Novacor drive-line exit site infections. Ann Thorac Surg 74 (2002) 1267-1268
73. Zierer A., Melby S.J., Voeller R.K., et al. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support. Ann Thorac Surg 84 (2007) 515-520
74. Siegenthaler M.P., Martin J., Pernice K., et al. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur J Cardiothorac Surg 23 (2003) 748-754
75. Vitali E., Lanfranconi M., Ribera E., et al. Successful experience in bridging patients to heart transplantation with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg 75 (2003) 1200-1204
76. Ankersmit H.J., Tugulea S., Spanier T., et al. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 354 (1999) 550-555
77. Ankersmit H.J., Edwards N.M., Schuster M., et al. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation 100 (1999) II211-II215
78. Itescu S., and John R. Interactions between the recipient immune system and the left ventricular assist device surface: immunological and clinical implications. Ann Thorac Surg 75 (2003) S58-S65
79. Samuels L.E., Holmes E.C., and Petrucci R. Psychosocial and sexual concerns of patients with implantable left ventricular assist devices: a pilot study. J Thorac Cardiovasc Surg 127 (2004) 1432-1435
80. Morales D.L., Catanese K.A., Helman D.N., et al. Six-year experience of caring for forty-four patients with a left ventricular assist device at home: safe, economical, necessary. J Thorac Cardiovasc Surg 119 (2000) 251-259
81. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 (2002) 1845-1853
82. Taylor A.L., Ziesche S., Yancy C., et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 351 (2004) 2049-2057
83. Kirklin J.K., Naftel D.C., Stevenson L.W., et al. INTERMACS database for durable devices for circulatory support: first annual report. J Heart Lung Transplant 27 (2008) 1065-1072